Table. 2.

Diagnostic accuracy of several cut-off points of HOMA-IR for the prediction of NAFLD

HOMA-IR SE (95% CI) SP (95% CI) PPV (95% CI) NPV (95% CI)
<1.0, ≥1.0 90.2 (89.6–90.9) 34.9 (33.6–36.3) 71.1 (70.2–80.0) 66.9 (65.0–68.8)
<1.5, ≥1.5 72.6 (71.6–73.6) 65.9 (64.6–67.3) 79.1 (78.2–80.0) 57.6 (56.3–58.9)
<1.665, ≥1.665 65.9 (64.9–67.0) 73.6 (72.4–74.9) 81.6 (80.7–82.5) 55.0 (53.7–56.2)
<2.0, ≥2.0 53.9 (52.8–54.9) 83.9 (82.9–85.0) 85.6 (84.6–86.5) 50.6 (49.5–51.8)
<2.5, ≥2.5 38.2 (37.1–39.2) 92.1 (91.3–92.8) 89.5 (88.5–90.5) 45.6 (44.6–46.6)

HOMA-IR, homeostatic model assessment of insulin resistance; NAFLD, non-alcoholic fatty liver disease; SE, sensitivity; CI, confidence interval; SP, specificity; PPV, positive predictive value; NPV, negative predictive value.

Korean J Fam Pract 2023;13:233~239 https://doi.org/10.21215/kjfp.2023.13.4.233
© KJFP